( Lancet . 2023;402(10399):350–352) It is well known in the field that pre-eclampsia is a large contributor to maternal and perinatal morbidity and mortality, with the burden disproportionately falling on lower income countries; much of the research surrounding pre-eclampsia and its management has been done in high-income countries, even though the disease burden in these countries is felt less severely. This article is a commentary arguing for more research in this area particularly for the settings in which people are most affected.
No takes yet. Share an insight, caveat, or question.
Cluver et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: